1. Home
  2. CFG vs UTHR Comparison

CFG vs UTHR Comparison

Compare CFG & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Group Inc.

CFG

Citizens Financial Group Inc.

HOLD

Current Price

$65.08

Market Cap

27.1B

Sector

Finance

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$578.00

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFG
UTHR
Founded
1828
1996
Country
United States
United States
Employees
17398
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.1B
25.1B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
CFG
UTHR
Price
$65.08
$578.00
Analyst Decision
Strong Buy
Buy
Analyst Count
18
14
Target Price
$69.83
$567.57
AVG Volume (30 Days)
4.3M
570.3K
Earning Date
04-16-2026
04-29-2026
Dividend Yield
2.85%
N/A
EPS Growth
N/A
13.07
EPS
N/A
27.86
Revenue
N/A
$1,483,300,000.00
Revenue This Year
$20.17
$7.08
Revenue Next Year
$8.30
$14.32
P/E Ratio
$16.85
$21.12
Revenue Growth
N/A
2.38
52 Week Low
$34.92
$272.18
52 Week High
$68.79
$607.89

Technical Indicators

Market Signals
Indicator
CFG
UTHR
Relative Strength Index (RSI) 65.53 58.95
Support Level $58.09 $464.92
Resistance Level $65.88 $607.89
Average True Range (ATR) 1.36 16.32
MACD 0.41 -0.80
Stochastic Oscillator 87.61 56.25

Price Performance

Historical Comparison
CFG
UTHR

About CFG Citizens Financial Group Inc.

Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through its subsidiaries, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The group's reportable business segments are: Consumer Banking and Commercial Banking. The majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services, including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management solutions, among others, through a network of branches and ATMs.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: